Human TRAIL ELISA Kit

Trail, 850.770.096

Recognizes both natural and recombinant soluble human Trail

Audige, A. et al., J Immunol., 2006; 177(9): 6227-37.
Bremer E. et al., Cancer Res., 2005; 65(8): 3380 - 3388
Cassatella, M. A. et al., J Leukoc Biol., 2006; 79(1) :123-32.
Castellino, G. et al., Lupus, 2007; 16(7): 479-482
Chehimi, J. et al., J. Virol., 2010; 84(6): 2762-2773
de Bruyn, M. et al., Clin. Cancer Res., 2011; 17: 5626-5637
Gasper-Smith, N. et al., J. Virol., 2008; 82: 7700-7710.
Ghorbel, M. T. et al., J. Thorac. Cardiovasc. Surg., 2010; 140(2): 337-345
Herbeuval J-P. et al., Blood, 2005; 105(6): 2458 - 2464
Herbeuval, J. P. et al., J Natl Cancer Inst ., 2003; 95(8): 611-21.
Indraccolo, S. et al., J Immunol., 2007; 178(2): 1122-35.
Jungel, A. et al., Ann Rheum Dis., 2006; 65(7): 910-2.
Koga Y. et al., Cancer Res., 2004; 64(3): 1037 - 1043
Lub-De Hooge M.N., Shock, 2004; 22(2): 186 - 188
Lub-de Hooge M.N. et al., Ann. Rheum. Dis, 2005; 64(6): 854 - 858
Ludwig A.T. et al., Cancer Res., 2004; 64(10): 3386 - 3390
Lü nemann JD. et al., J. Immunol., 2002; 168(10): 4881 - 4888
Merino, D. et al., Mol Cell Biol., 2006; 26(19): 7046-55
Potu, H. et al., Cancer Res., 2010; 70(2): 655-665
Simons, M. P. et al., Infect Immun., 2007; 75(3): 1265-71
Tecchio C. et al., Blood, 2004; 103(10): 3837 - 3844
Vermot-Desroches C. et al., Cell Immunol., 2005; 2 36(1-2):86-91
Wandinger KP et al., Lancet, 2003; 361(9374) : 2036 - 2043.
Wegrzynowska, M. et al., Poster Session 3 Europace 13 (suppl_3):10.1093/europace/eur229
Yang, L. et al., Blood, 2010; 116(20):4307-4316

Serum
Plasma
Cell culture supernatant

48 (Discovery), 96, 192 tests